This topic contains a solution. Click here to go to the answer

Author Question: An intravenous hypertonic solution containing dextrose, proteins, vitamins, and minerals is known as ... (Read 49 times)

theo

  • Hero Member
  • *****
  • Posts: 698
An intravenous hypertonic solution containing dextrose, proteins, vitamins, and minerals is known as
 
  A) Cellular hydration
  B) Volume expander
  C) Total parenteral nutrition
  D) Blood transfusion therapy

Question 2

Which of the following clients would be a candidate for total parenteral nutrition?
 
  A) A client with diabetic ketoacidosis
  B) A postoperative appendectomy client
  C) A client with colitis and bloody diarrhea
  D) A client receiving intravenous antibiotics



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

morrie123456

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

Ans: C

Answer to Question 2

Ans: C




theo

  • Member
  • Posts: 698
Reply 2 on: Jul 22, 2018
Thanks for the timely response, appreciate it


sarah_brady415

  • Member
  • Posts: 328
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library